FDA Inspection 1025118 — Sung-Bae Kim, MD, PhD, Professor/Dept of Oncology
The FDA completed an inspection of Sung-Bae Kim, MD, PhD, Professor/Dept of Oncology on August 25, 2017 in Seoul. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seoul (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)